Argeris N Karabelas is of REGENXBIO Inc.. Currently has a direct ownership of 11,286 shares of RGNX, which is worth approximately $123,017. The most recent transaction as insider was on Jul 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $11.27 per share, resulting in proceeds of $112,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.3K
73.74% 3M change
73.74% 12M change
Total Value Held $123,017

ARGERIS N KARABELAS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
SELL
Open market or private sale
$112,700 $11.27 p/Share
10,000 Reduced 46.98%
11,286 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$37,600 $3.76 p/Share
10,000 Added 31.96%
21,286 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
-
4,790 Added 29.8%
11,286 Common Stock
Jun 02 2023
BUY
Grant, award, or other acquisition
-
3,486 Added 34.92%
6,496 Common Stock
Jun 03 2022
BUY
Grant, award, or other acquisition
-
3,010 Added 50.0%
3,010 Common Stock

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
ANK

Argeris N Karabelas

Bridgewater, NJ

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX